Page 73 - Read Online

Page 10 of 13 Zhang et al. Cancer Drug Resist 2024;7:30 https://dx.doi.org/10.20517/cdr.2024.62

Exploring the potential of miRNAs and circRNAs as diagnostic and prognostic biomarkers for BC
represents a paradigm shift in the field of oncology, offering possibilities for more precise and personalized
diagnostic and therapeutic strategies for BC. By leveraging the unique expression profiles of these
non-coding RNAs, clinicians may soon be able to stratify patients according to their molecular
characteristics to guide treatment decisions and improve patient outcomes. Furthermore, the development
of innovative technologies for the detection and quantification of miRNAs and circRNAs holds promise for
implementing non-invasive and cost-effective screening strategies, particularly in resource-limited settings.
In conclusion, research on miRNAs and circRNAs may lead to significant changes in the management of
BC patients and improve diagnosis and prognosis.

DECLARATIONS
Acknowledgments
We thank Figdraw (https://www.home-for-researchers.com/) for the preparation of the graphic abstract,
Figure 1, and Figure 2. Figure 3 was partly generated using Servier.
Medical Art, provided by Servier, licensed under a Creative Commons Attribution 3.0. unported license.

Authors’ contributions
Conceptualization and design of the study: Zhang M (Meilan Zhang), Guo Z, Wang H, Tan W, Wang S
Original drafting: Zhang M (Meilan Zhang), Zheng Z, Zhang M (Mengli Zhang), Wang S
Preparation of figures: Liu R, Wang S
Review and editing: Zhang M (Meilan Zhang), Guo Z, Wang H, Tan W
All authors have read and agreed to the published version of the manuscript.

Availability of data and materials
Not applicable.

Financial support and sponsorship
This work was supported by the Science and Technology Project of Guangzhou City (No. 202201010029).

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2024.

REFERENCES
1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin 2024;74:229-63. DOI PubMed
2. Nolan E, Lindeman GJ, Visvader JE. Deciphering breast cancer: from biology to the clinic. Cell 2023;186:1708-28. DOI PubMed
3. Wang J, Li B, Luo M, et al. Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical
significance. Signal Transduct Target Ther 2024;9:83. DOI PubMed PMC
4. Purrahman D, Mahmoudian-Sani MR, Saki N, Wojdasiewicz P, Kurkowska-Jastrzębska I, Poniatowski ŁA. Involvement of